Copyright
©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 82-87
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.82
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.82
Non-LC group, n = 202 | LC group, n = 100 | P-value | |
Etiology | |||
HBV | 43 (21.2%) | 10 (10.0%) | |
HCV | 89 (44.1%) | 72 (72.0%) | |
NBNC | 70 (34.7%) | 18 (18.0%) | < 0.001 |
Edmonson-Steiner grade | |||
I | 30 (30.0%) | 36 (17.8%) | 0.07 |
II | 64 (64.0%) | 151 (74.8%) | |
III | 4 (4.0%) | 13 (6.4%) | |
IV | 2 (2.0%) | 2 (1.0%) | |
PLT, × 104/μL | 18.9 ± 8.1 | 11.6 ± 4.6 | < 0.0001 |
MPV, fL | 10.2 ± 0.9 | 10.8 ± 0.9 | < 0.0001 |
MPV/PLT ratio | 0.64 ± 0.30 | 1.10 ± 0.51 | < 0.0001 |
PT, % | 92.9 ± 11.7 | 82.5 ± 11.1 | < 0.0001 |
AST, IU/L | 42 ± 26 | 51 ± 23 | < 0.0001 |
ALT, IU/L | 40 ± 30 | 47 ± 33 | 0.02 |
Total-bilirubin, mg/dL | 0.67 ± 0.23 | 0.90 ± 0.34 | < 0.0001 |
Albumin, g/dL | 3.8 ± 0.5 | 3.6 ± 0.4 | 0.01 |
Cholinesterase, IU/L | 235 ± 80 | 193 ± 60 | < 0.0001 |
Type 4 collagen, ng/mL | 6.3 ± 2.4 | 9.1 ± 4.4 | 0.04 |
Hyaluronic acid, ng/mL | 147 ± 179 | 312 ± 318 | < 0.0001 |
ICGR15, % | 14.1 ± 8.3 | 22.1 ± 12.1 | < 0.0001 |
GSA Rmax, mg/min | 0.62 ± 0.21 | 0.44 ± 0.17 | < 0.0001 |
Odds ratio | P-value | 95%CI | ||
MPV/PLT ratio | ≥ 0.71, n = 151 | 3.71 | < 0.0001 | 1.94-7.28 |
< 0.71, n = 151 | ||||
PT, % | ≥ 89.0, n = 151 | 2.68 | 0.0018 | 1.44-5.06 |
< 89.0, n = 151 | ||||
AST, IU/L | ≥ 39, n = 155 | 3.30 | 0.01 | 1.30-9.09 |
< 39, n = 147 | ||||
ALT, IU/L | ≥ 34, n = 153 | 2.57 | 0.04 | 1.02-7.09 |
< 34, n = 149 | ||||
Total-bilirubin, mg/dL | ≥ 0.7, n = 177 | 1.89 | 0.04 | 1.00-3.61 |
< 0.7, n = 125 | ||||
Albumin, g/dL | ≥ 3.8, n = 168 | 0.95 | 0.89 | 0.47-1.89 |
< 3.8, n = 134 | ||||
Cholinesterase, IU/L | ≥ 211, n = 152 | 0.98 | 0.96 | 0.48-1.98 |
< 211, n = 150 | ||||
Type 4 collagen, ng/mL | ≥ 6.5, n = 166 | 0.95 | 0.86 | 0.51-1.72 |
< 6.5, n = 136 | ||||
Hyaluronic acid, ng/mL | ≥ 124, n = 153 | 2.28 | 0.008 | 1.23-4.26 |
< 124, n = 149 | ||||
ICGR15, % | ≥ 14.3, n = 151 | 1.40 | 0.30 | 0.72-2.68 |
< 14.3, n = 151 | ||||
GSA Rmax, mg/min | ≥ 0.555, n = 151 | 1.51 | 0.24 | 0.75-3.04 |
< 0.555, n = 151 |
- Citation: Iida H, Kaibori M, Matsui K, Ishizaki M, Kon M. Ratio of mean platelet volume to platelet count is a potential surrogate marker predicting liver cirrhosis. World J Hepatol 2018; 10(1): 82-87
- URL: https://www.wjgnet.com/1948-5182/full/v10/i1/82.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i1.82